文献速递特殊人群用药治疗药物监测与药物基因组学

早产子痫前期患者埃索美拉唑群体药代动力学研究

Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia.
PubMed 文献 · Br J Clin Pharmacol · 2022-06-03

本研究纳入10例早产子痫前期孕妇和49例非妊娠受试者,建立埃索美拉唑群体药代动力学模型。二室模型拟合良好;单次给药后孕妇清除率较非妊娠者低42.2%(14.9-61.6%),可能因CYP2C19抑制;非妊娠者多次给药后强代谢者清除率降低54.9%(48.2-63.5%),生物利用度提高33%(10.0-52.0%)。

要点

  • 早产子痫前期孕妇单次给药后埃索美拉唑清除率较非妊娠者低42.2%。
  • 非妊娠强代谢者多次给药后清除率降低54.9%,生物利用度提高33%。
  • 妊娠期CYP2C19已受抑制,多次给药自身抑制导致的暴露增幅预计远低于非妊娠者。

核心结论

  • 早产子痫前期孕妇单次给药后埃索美拉唑清除率较非妊娠者低42.2%(14.9-61.6%),可能因CYP2C19抑制。
  • 非妊娠强代谢者多次给药后清除率较单次给药低54.9%(48.2-63.5%),生物利用度高33%(10.0-52.0%),可能因CYP2C19自身抑制。
  • 妊娠期CYP2C19已受抑制,多次给药自身抑制导致的暴露增幅预计远低于非妊娠者。

研究设计与样本

  • 基于10例早产子痫前期孕妇和49例非妊娠受试者的数据建立埃索美拉唑群体药代动力学模型。
  • 二室模型可良好描述数据。

主要发现

  • 孕妇单次给药后清除率较非妊娠者低42.2%(14.9-61.6%)。
  • 非妊娠强代谢者多次给药后清除率较单次给药低54.9%(48.2-63.5%)。
  • 非妊娠强代谢者多次给药后生物利用度较单次给药高33%(10.0-52.0%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Esomeprazole is a proton pump inhibitor being investigated for treatment of preeclampsia. Esomeprazole pharmacokinetics during pregnancy are unknown. We used data from 10 pregnant participants with preterm preeclampsia, and 49 non-pregnant participants to develop a population pharmacokinetic model of esomeprazole. A two-compartment model described the data well. In pregnant participants after single dose, clearance was 42.2% (14.9-61.6%) lower compared to non-pregnant, most likely due to inhibition of CYP2C19. In non-pregnant participants after repeated dosing, clearance was 54.9% (48.2-63.5%) lower in extensive metabolizers and bioavailability was 33% (10.0-52.0%) higher compared to single dosing, which could be due to autoinhibition of CYP2C19. During pregnancy, the CYP2C19 autoinhibition effect with repeated dosing is expected to lead to much lower increase in exposure compared to non-pregnant individuals, since CYP2C19 is already inhibited due to pregnancy.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Gebreyesus MS, Decloedt EH, Cluver CA, et al. Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia. Br J Clin Pharmacol. 2022. PMID: 35599445. doi:10.1111/bcp.15416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。